TARBP2 and urinary bladder carcinoma: Our findings not only demonstrate the universality of this novel phenomenon but also dictate the functionality of a common molecular mechanism that can act independently of the malignancy grade and tumor tissue origin, thus strongly supporting the essential contribution of TRBP2 as a negative regulator to successful mitosis implementation in bladder carcinoma environments.